Back
Day Range
$8.95
$11.00
52-Week Range
$8.95
$12.95
Volume
100
50D / 200D Avg
$11.67
/
$12.63
Prev Close
$8.95
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 12.3 | 0.4 |
| P/B | 1.9 | 2.9 |
| ROE % | 16.4 | 3.7 |
| Net Margin % | 7.2 | 3.8 |
| Rev Growth 5Y % | 2.6 | 10.0 |
| D/E | 1.3 | 0.2 |
Key Takeaways
Revenue grew 2.58% annually over 5 years — modest growth
Earnings grew 29.10% over the past year
ROE of 16.35% — decent returns on equity
Generating 156.34M in free cash flow
P/E of 12.25 — trading at a low valuation
PEG of 0.54 suggests growth is underpriced
Growth
Revenue Growth (5Y)
2.58%
Revenue (1Y)-4.60%
Earnings (1Y)29.10%
FCF Growth (3Y)15.60%
Quality
Return on Equity
16.35%
ROIC7.82%
Net Margin7.24%
Op. Margin10.76%
Safety
Debt / Equity
1.26
Current Ratio0.64
Interest Coverage6.25
Valuation
P/E Ratio
12.25
P/B Ratio1.94
EV/EBITDA13.04
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4.60% | Revenue Growth (3Y) | -0.31% |
| Earnings Growth (1Y) | 29.10% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2.58% | Earnings Growth (5Y) | 3.55% |
| Profitability | |||
| Revenue (TTM) | 1.28B | Net Income (TTM) | 92.57M |
| ROE | 16.35% | ROA | 6.43% |
| Gross Margin | 21.09% | Operating Margin | 10.76% |
| Net Margin | 7.24% | Free Cash Flow (TTM) | 156.34M |
| ROIC | 7.82% | FCF Growth (3Y) | 15.60% |
| Safety | |||
| Debt / Equity | 1.26 | Current Ratio | 0.64 |
| Interest Coverage | 6.25 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 12.25 | P/B Ratio | 1.94 |
| P/S Ratio | 0.89 | PEG Ratio | 0.54 |
| EV/EBITDA | 13.04 | Dividend Yield | 0.04% |
| Market Cap | 1.13B | Enterprise Value | 1.79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.28B | 1.34B | 1.29B | 1.26B | 1.15B |
| Net Income | 92.57M | 71.70M | -42.20M | 24.40M | 80.50M |
| EPS (Diluted) | 0.73 | 0.57 | -0.33 | 0.19 | 0.63 |
| Gross Profit | 269.60M | 790.20M | 303.20M | 733.40M | 665.80M |
| Operating Income | 137.55M | 116.10M | -14.70M | 33.90M | 110.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.44B | 1.40B | 1.42B | 1.48B | 1.45B |
| Total Liabilities | 856.68M | 850.20M | 904.10M | 887.40M | 839.70M |
| Shareholders' Equity | 583.98M | 548.20M | 515.40M | 592.00M | 608.90M |
| Total Debt | 734.82M | 570.00M | 635.80M | 607.00M | 557.30M |
| Cash & Equivalents | 75.17M | 65.20M | 37.70M | 40.20M | 38.10M |
| Current Assets | 207.62M | 208.20M | 192.60M | 189.70M | 172.80M |
| Current Liabilities | 326.08M | 312.50M | 300.30M | 306.90M | 392.00M |